Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling
Ikuo Nakamura(Hyogo Medical University), Lewis R. Roberts(Mayo Clinic)
Cited by 61
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
The role of hepatic resection in the treatment of hepatocellular cancer
|Hepatology|2015|415
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
|Cell Reports|2018|366